.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Propafenone hydrochloride - Generic Drug Details

« Back to Dashboard
Propafenone hydrochloride is the generic ingredient in three branded drugs marketed by Mylan Pharms Inc, Watson Labs, Glaxosmithkline Llc, Vintage Pharms, Par Pharm, Orion Corp Orion, Ani Pharms Inc, Watson Labs Inc, Nesher Pharms, and Sun Pharm Inds, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for propafenone hydrochloride. Twenty suppliers are listed for this compound.

Summary for Generic Name: propafenone hydrochloride

Tradenames:3
Patents:0
Applicants:10
NDAs:11
Drug Master File Entries: see list11
Suppliers / Packaging: see list20
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices

Pharmacology for Ingredient: propafenone hydrochloride

Drug ClassAntiarrhythmic
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Nesher Pharms
PROPAFENONE HYDROCHLORIDE
propafenone hydrochloride
TABLET;ORAL076193-001Feb 7, 2002DISCNNo► subscribe► subscribe
Ani Pharms Inc
PROPAFENONE HYDROCHLORIDE
propafenone hydrochloride
TABLET;ORAL076550-003Apr 23, 2004RXNo► subscribe► subscribe
Par Pharm
PROPAFENONE HYDROCHLORIDE
propafenone hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL078540-001Oct 18, 2010RXNo► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: propafenone hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline Llc
RYTHMOL SR
propafenone hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL021416-001Sep 4, 20035,681,588► subscribe
Glaxosmithkline Llc
RYTHMOL SR
propafenone hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL021416-003Sep 4, 20035,681,588► subscribe
Glaxosmithkline Llc
RYTHMOL SR
propafenone hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL021416-002Sep 4, 20035,681,588► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc